Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1838-1843

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demuth, K.
Right arrow Articles by Girerd, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demuth, K.
Right arrow Articles by Girerd, X.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1998;18:1838-1843.)
© 1998 American Heart Association, Inc.


Original Contributions

Opposite Effects of Plasma Homocysteine and the Methylenetetrahydrofolate Reductase C677T Mutation on Carotid Artery Geometry in Asymptomatic Adults

Karine Demuth; Nicole Moatti; Olivier Hanon; Marie Odile Benoit; Michel Safar; Xavier Girerd

From the Department of Biochemistry (K.D., N.M., M.O.B.), Department of Internal Medicine, and INSERM U 337 (O.H., M.S., X.G.), Broussais Hospital, Paris, France.

Correspondence to Pr Michel Safar, Service de Médecine Interne, Hôpital Broussais, 96 rue Didot, 75014 Paris, France.

Abstract—Studies of symptomatic patients have identified hyperhomocysteinemia as an independent risk factor for vascular disease. In case-control studies, a point mutation (C677T) in the gene encoding 5,10-methylenetetrahydrofolate reductase (MTHFR) has also been linked to an increased risk of vascular disease through its effect on homocysteinemia. Our aim was to extend these observations to asymptomatic subjects by studying the influence of both homocysteinemia and its mutation on carotid artery geometry. We examined 144 subjects free of atherosclerotic lesions. Fasting homocysteinemia was measured by high-performance liquid chromatography with fluorometric detection. MTHFR genotype was analyzed by polymerase chain reaction followed by HinfI digestion. Carotid artery geometry was characterized by internal diameter and intima-media thickness, as assessed by a high-resolution echo-tracking system. Subjects in the upper homocysteine tertile had a greater carotid internal diameter than did subjects in the middle and lower tertiles (6516±770 versus 6206±641 and 5985±558 µm, respectively; P<0.001). Subjects homozygous for the mutation had a smaller carotid artery internal diameter than did subjects heterozygous or homozygous for the wild-type allele (5846±785 versus 6345±673 and 6199±671 µm, respectively; P<0.05). Homocysteinemia was not significantly increased in subjects homozygous for the mutation. In multivariate regression analysis, homocysteinemia was independently and positively associated with lumen diameter (P=0.0008) and wall thickness (P=0.020). Conversely, homozygosity for the mutation was negatively associated with internal diameter (P=0.009). These preliminary data suggest that mildly elevated homocysteinemia and homozygosity for the MTHFR C677T mutation are associated with opposite preclinical modifications of carotid artery geometry. If confirmed, these results may have important implications for new treatment strategies for vascular disease before the onset of clinical manifestations.


Key Words: homocysteine • methylenetetrahydrofolate gene • artery • carotid • remodeling




This article has been cited by other articles:


Home page
J. Nutr.Home page
C. L. Guinotte, M. G. Burns, J. A. Axume, H. Hata, T. F. Urrutia, A. Alamilla, D. McCabe, A. Singgih, E. A. Cogger, and M. A. Caudill
Methylenetetrahydrofolate Reductase 677C->T Variant Modulates Folate Status Response to Controlled Folate Intakes in Young Women
J. Nutr., May 1, 2003; 133(5): 1272 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K.-S. Cheng, D. P. Mikhailidis, G. Hamilton, and A. M. Seifalian
A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors
Cardiovasc Res, June 1, 2002; 54(3): 528 - 538.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Butler, A. D. Morris, and A. D. Struthers
The T Allele of The C677T 5,10-Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism May Protect Endothelial Function in Young, Normal Subjects
Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 193 - 194.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Brattstrom and D. E. Wilcken
Homocysteine and cardiovascular disease: cause or effect?
Am. J. Clinical Nutrition, August 1, 2000; 72(2): 315 - 323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
P. M Ueland, H. Refsum, S. A. Beresford, and S. E. Vollset
The controversy over homocysteine and cardiovascular risk
Am. J. Clinical Nutrition, August 1, 2000; 72(2): 324 - 332.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. G. Bostom and J. Selhub
Homocysteine and Arteriosclerosis : Subclinical and Clinical Disease Associations
Circulation, May 11, 1999; 99(18): 2361 - 2363.
[Full Text] [PDF]